Riskpilot← Back to searchSign inGet full accessInion Oy
OYActiveY-tunnus 2370567-9Lääkärinkatu 2Manufacture of medical and dental instruments and supplies · NACE 3250Est. 201032 employees
Revenue 2024
EUR 14,8M
EBITDA margin
7.1%
Equity ratio
22.7%
Financial strength
Net profit 2024
EUR 0
32 employees
| Revenue | EUR 14,8M | — |
| EBITDA | EUR 1,1M | — |
| Net profit | EUR 0 | — |
| Total assets | EUR 48,4M | -12% |
| Equity | EUR 11M | — |
| Employees | 32 | — |
Legal name
Inion Oy
Y-tunnus number
2370567-9
Legal form
Osakeyhtiö
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
10. marraskuuta 2010
Share capital
EUR 100 000
Employees
32 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja yksin
Company purpose
Yhtiön toimiala on, itse tai omistamiensa tytäryhtiöiden kautta, lääketieteellisten välineiden ja biomateriaalituotteiden tutkimus, kehittäminen, valmistaminen, lisensointi, markkinointi ja myynti kotimaassa ja ulkomailla sekä muu toimialaan liittyvä toiminta. Yhtiö voi, itse tai omistamiensa tytäryhtiöiden kautta, harjoittaa myös muuta liiketoimintaa ja tutkimustyötä sekä harjoittaa tietotaidon ja palveluiden myyntiä, tarjoamista ja lisensiointia toimintansa puitteissa. Lisäksi Yhtiö voi toimialansa puitteissa ostaa ja myydä sekä ottaa ja antaa vuokralle kiinteistöjä, sekä omistaa ja hallita osakkeita ja muita arvopapereita harjoittamatta kuitenkaan ammattimaista arvopaperikauppaa.
Address
Lääkärinkatu 2
Phone
+3580108306600
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 3 646 | 3 415 | 3 607 | 5 063 | 9 673 | 0 | 14 847 |
| Staff expenses | −2 403 | −1 234 | −781 | −1 028 | −1 424 | −0 | −2 323 |
| EBITDA | −875 | −819 | −818 | −503 | 2 560 | 0 | 1 061 |
| Depreciation & amort. | −282 | −240 | −206 | −208 | −208 | −0 | −2 360 |
| EBIT | −1 157 | −1 059 | −1 024 | −711 | 2 352 | 0 | 0 |
| Net financials | −9 | −18 | −77 | 29 | 32 | 0 | 36 |
| Profit before tax | −884 | −1 016 | −896 | −475 | 2 497 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −15 |
| Net profit | −884 | −1 016 | −896 | −475 | 2 497 | 0 | 0 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 13 202 | 26 818 | 27 083 | 27 717 | 29 432 | 55 284 | 48 429 |
| Equity | 10 165 | 9 101 | 10 296 | 10 867 | 14 260 | 0 | 10 995 |
| Long-term debt | 811 | 484 | 299 | 128 | 47 | 12 | 0 |
| Short-term debt | 2 227 | 17 232 | 16 488 | 16 722 | 15 125 | 34 421 | 28 503 |
| Total debt | 3 037 | 17 716 | 16 787 | 16 849 | 15 172 | 0 | 28 503 |
EBITDA margin
7.1%
This company
15.8%
Market median
-55% vs market
20182024
Equity ratio
22.7%
This company
38.2%
Market median
-41% vs market
20182024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20182024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20182024
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20182024
Debt / equity
3.40×
This company
0.62×
Market median
-448% vs market
20182024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Audit | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairperson | 2010 | — | — | |
| Board of Directors | 2010 | — | — | |
YW | Board of Directors | 2010 | — | — |
| Board of Directors | 2023 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Inion Oy (this company)
Inion Inc (USA)Inion (Tianjin) Medical Device Co. LtdBoard members of Inion Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pekka Kalevi Johannes Hiltunen | Audit | 0 companies |
| Yiwu Zhao | Chairperson | 0 companies |
| Minli Zhao | Board of Directors | 0 companies |
| Yan Wang | Board of Directors | 0 companies |
| Linlin Wang | Board of Directors | 0 companies |